PRESS RELEASE published on 10/23/2023 at 14:05, 2 years 1 month ago With PlexxusAI, FutureRx(R) Debuts a Groundbreaking Generative AI-Enabled Approach to Help Health Plans Improve Star Ratings, MTM Program Outcomes and Medication Adherence
PRESS RELEASE published on 10/17/2023 at 14:00, 2 years 1 month ago FutureRx(R) Part D Stars Selected by Imperial Health Plans
PRESS RELEASE published on 06/20/2023 at 15:30, 2 years 5 months ago FutureRx Appoints Eric Grossman as Chief Commercial Officer
PRESS RELEASE published on 04/26/2023 at 15:00, 2 years 7 months ago FutureRx Expands the FRx Marketplace with Pharmacy and Medical Rebate Management Solutions from Nuwae
PRESS RELEASE published on 02/21/2023 at 19:00, 2 years 9 months ago FutureRx Launches Paradigm-Shifting Healthcare Platform for Health Plans and PBMs
Published on 12/05/2025 at 02:35, 4 hours 57 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 32 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 27 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 32 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 31 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 1 minute ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 41 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 6 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 16 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 17 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 32 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 32 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 47 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 47 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
